0001171843-17-003747.txt : 20170621
0001171843-17-003747.hdr.sgml : 20170621
20170621161928
ACCESSION NUMBER: 0001171843-17-003747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170620
FILED AS OF DATE: 20170621
DATE AS OF CHANGE: 20170621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS PAUL J
CENTRAL INDEX KEY: 0001309702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 17923091
MAIL ADDRESS:
STREET 1: 61 HARTFORD STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2017-06-20
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001309702
HASTINGS PAUL J
C/O PROTEON THERAPEUTICS, INC.
200 WEST STREET
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
1.30
2017-06-20
4
A
0
6666
0
A
2027-06-19
Common Stock, $0.001 par value
6666
6666
D
The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders.
/s/ George A. Eldridge, attorney-in-fact for Paul J. Hastings
2017-06-21